Cel Sci Corporation (CVM)

[learning curve]

Here is a bit to chew on:
Muktykine is 100% believed to be successful by management.
My hypothesis is the idiotic and procastinated FDA.
Without this procrastination Geert and insiders would not be allowed to equally position themselves for their work in the value of the company. (You can't call an emergency shareholder meetings to increase compensation!) The meeting allows Geert to reposition himself equivalently with the funders.
Can you imagine being a founder and get diluted 50%, but you could regain your position if you procrastinate for a few months? Would you care if you were essentially going to bk?

So, that's great!

-----
But Cvm doesn't control FDA outcome. Thus can't control timeline of preliminary results.
They could have the most positive results ever and not be able to share them becuase they aren't to protocol.
(FYI: this is why Geert is NOT and can NOT buy on open market).

------

The overlapping timelines are a complete wrench, but not over complex either.
The nine monthers from December will be intact for prelim results as long as FDA doesn't completely shut ph3 down.

-----
Leading me to believe that arbitration could be a long long long way away...

-----
I hate to hate to hit replay: but how can arbitrator determination without FDA result?